Medical Devices & Surgical Technology Week articles from November 2004

Medical Devices & Surgical Technology Week archives from November 2004

Novel techniques improve control of macromolecular reactions.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- A novel assay and DNA stretching technique can improve control of macromolecular reactions. "Conformational control of macromolecules is useful for efficient chemical and biochemical reactions,"...

Thrombin peptide-loaded microspheres improve bone healing in rabbits.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Microspheres loaded with thrombin peptide improved bone healing in a rabbit model. In a recent study from the United States, the "synthetic peptide, TP508 (Chrysalin), was delivered to rabbit...

Novel assay improves diagnosis of myotonic dystrophy type 2.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- A novel assay improves the accuracy of myotonic dystrophy type 2 (DM2) diagnosis. DM2 "lacks the expansion on chromosome 19q13 present in DM1 and is characterized by a mutation on 3q21,"...

Java-based application facilitates microarray experiment tracking.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- A novel Java-based application facilitates the processing of data from microarray experiments. "Microarrays allow monitoring of gene expression for tens of thousands of genes in parallel and are...

Pneumatic impact device enables accurate rat model of SCI.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- A rat model of spinal cord injury (SCI) has been developed with the aid of a pneumatic impact device. "An animal model of spinal cord trauma is essential for understanding the injury mechanisms,...

FDA approves medical device to treat AAA.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Cook, Inc., a privately held medical-device manufacturer, announced that the U.S. Food and Drug Administration (FDA) has approved the company's next-generation solution for abdominal aortic aneurysms...

New technique to repair aneurysms safer.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Repairing a life-threatening bulge in a major stomach artery by threading a patch up from the groin appears to sharply cut the short-term risk of death and complications, compared with traditional...

Multiresistant Acinetobacter baumannii outbreak occurred in surgical room.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Multi-resistant Acinetobacter baumannii outbreak occurred in a surgical room in Germany. "Outbreaks of Acinetobacter baumannii demonstrating multiple antibiotic resistance, including meropenem...

Loss of clone with FLT3 gene mutation at relapse does not improve AML prognosis.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- The loss of a clone with an FLT3 gene mutation at relapse does not improve the prognosis of acute myeloid leukemia. According to recent research from Germany, "Internal tandem duplications (ITDs)...

Membrane Cofactor Protein identified as adenovirus receptor.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Membrane Cofactor Protein is identified as the adenovirus receptor. "A tandem mass spectrometry-based approach is demonstrated for detecting a receptor for Ad37, one of the causative agents for...

Genes involved in valproic acid teratogenicity identified.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Genes involved in teratogenicity induced by the antiepileptic drug valproic acid (VPA) have been identified. "Embryonic development is a highly coordinated set of processes that depend on...

Candela enters exclusive distribution agreement for China.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Candela Corp. (CLZR), a company focused on the development and commercialization of aesthetic laser systems, and Chindex International, Inc., (CHDX), an independent American provider of western...

Study: Anti-dust mite covers effective in reducing allergens.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- A new study provides evidence that people who have allergic asthma and use dust mite-impermeable bed covers have improved peak flow measurements. These findings are featured in the October 2004...

Biotechcompany scientist presented with award from Alzheimer Association.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Prana Biotechnology Limited (NASDAQ:PRAN)(NASDAQ:ASX:)(NASDAQ:PBT) announced that Dr. Ashley Ian Bush, cofounding scientist and senior scientific consultant to Prana Biotechnology, was named a 2004...

NSAID prodrugs show promise for CNS delivery.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- A series of prodrugs of non-steroidal anti-inflammatory drugs (NSAIDs) show promise for CNS delivery of these agents. NSAIDs "have been proposed to prevent or to cure Alzheimer disease," according...

p-tau 231 assay improves early stage Alzheimer disease detection.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- An assay developed by Applied NeuroSolutions (APNS), when combined with magnetic resonance imaging (MRI), was shown to identify neural signposts in patients with mild cognitive impairment (MCI), a...

JCAHO Sentinel Event Alert issued targeted at preventing anesthesia awareness.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Aspect Medical Systems (ASPM) announced that the Joint Commission on Accreditation of Healthcare Organizations (JCAHO) has issued a new Sentinel Event Alert (issue no. 32) aimed at preventing and...

Company introduces low permeability AAA Device.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- W. L. Gore & Associates, Inc., a manufacturer of expanded polytetrafluoroethylene (ePTFE) vascular grafts and endovascular devices including the GORE EXCLUDER Bifurcated Endoprosthesis, announced...

System may aid therapies to lower incidence of acute coronary artery diseases.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- A recent report described an intravascular probe for detection of vulnerable plaque. Investigators in the United States report, "Coronary angiography defines geometry of lumen of artery. However,...

Antiestrogenic drug combinations may be used for glioblastoma malignancies.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Antiestrogenic drug combinations may be used for glioblastoma malignancies. According to researchers in Turkey, "The antitumor activity of nonsteroidal antiestrogens on C6 and low passage of human...

FDA approves first U.S. implants of Philos II DR-T pacemaker.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Biotronik, Inc., announced U.S. Food and Drug Administration (FDA) approval and first implants of a second-generation Home Monitoring product: the Philos II DR-T pacemaker. The device is part of a...

Synthetic zeolites used for arsenate removal from pollutant water.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Synthetic zeolites are used for arsenate removal from pollutant water. "Arsenic is known to be a hazardous contaminant in drinking water that causes arsenical dermatitis and skin cancer. In the...

Research shows gelatine stimulates synthesis of type II collagen.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Collagen hydrolysate (CH), a special type of gelatine, was shown to stimulate synthesis of type II collagen in a study presented at the annual meeting of the American Society for Bone and Mineral...

Bioassay detects soluble MAdCAM-1 in body fluids.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Researchers have developed a bioassay to detect soluble MAdCAM-1 in body fluids. According to recent research from New Zealand, "Mucosal addressin cell adhesion molecule (MAdCAM-1) is a key player...

Company addresses possible reimbursement for VentrAssist LVAS.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Ventracor, Ltd., (VCR), said there was evidence the cost of its artificial heart devices used in its pending U.S. clinical trials would be fully reimbursed and there was potential for reimbursement at...

Suite of asthma control and asthma impact surveys launched.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- QualityMetric Incorporated announced launch of a full suite of asthma control and asthma impact surveys for adults and children that measure health-related quality of life (HRQoL) from the patient...

MRI and spatially enhanced cluster analysis provide method to quantify plaque.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- A recent report described quantification of human atherosclerotic plaques using spatially enhanced cluster analysis of multicontrast-weighted magnetic resonance images. "One of the current...

Biphasic cardioversion allows comparable success rates with lower energies.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Researchers have investigated the impact of biphasic electrical cardioversion of atrial fibrillation on early recurrent atrial fibrillation and shock efficacy. According to recent research published...

Automatic analysis of auditory nerve as efficient as human experts.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- An automatic analysis system of the auditory nerve as efficient as human experts. "The auditory nerve's electrically evoked compound action potential is recorded in deaf patients equipped with the...

Biotech firm lauds Nobel winner, announces olfactory-based government contract.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Joseph K. Pagano, chairman of the board of Sentigen Holding Corp. (SGHL), a biotechnology company, extended congratulations to Dr. Richard Axel, Sentigen's long term good friend and consultant, on being...

Carter-Thomason CloseSure System XL receives society's innovative product award.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Inlet Medical Inc. has received a 2004 Innovative Product of the Year Award for the Carter-Thomason CloseSure System XL from the Society of Laparoendoscopic Surgeons (SLS). The SLS Innovation of...

Medical devices company ranks 30th on the Minnesota Technology Fast 50 program.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Synovis Life Technologies, Inc. (SYNO) placed 30th on Deloitte's Technology Fast 50 Program for Minnesota, a ranking of the 50 fastest-growing technology companies in the state. The Technology Fast...

Nanotechnology-based life sciences company's founder wins NIH award.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Nanosphere Inc. announced that its founder, Chad A. Mirkin, PhD, has been selected as one of the first recipients of the U.S. National Institutes of Health (NIH) Director's Pioneer Award. The $2.5...

Oligonucleotide array technology rapidly detects foodborne pathogenic bacteria.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Oligonucleotide array technology rapidly detects foodborne pathogenic bacteria. According to a study from China, "A rapid and accurate method for detection for common pathogenic bacteria in...

Significance of microbial interactions in biooxidation of pyrite.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Significance of microbial interactions in biooxidation of pyrite. Researchers writing in Biotechnology and Bioengineering explained, "The oxidative dissolution of pyrite (FeS2) by pure and mixed...

Swedish company presents mass screening tests at investment conference.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Swedish blood diagnostics company LifeAssays Inc. presented its mass screening and point-of-care tests on Oct. 21 at the Windhover Information and Medtech Insight's "Investment In Innovation" Event, at...

Triclosan's insertion in cell membrane may account for its antibacterial effect.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Triclosan's insertion into the bacterial cell membrane may account for its antibacterial effect. According to a study from Spain, "Triclosan is a hydrophobic antibacterial agent used in...

Obesity surgery can cure diabetes, high blood pressure and other ills.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Patients who undergo obesity, or bariatric, surgery get far more than cosmetic benefits, many also shed fat-related ailments including diabetes, high blood pressure and high cholesterol, researchers...

Peptidomics offers sensitive search for biomarkers.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- The German biotech company BioVisioN opens up new possibilities for peptide biomarker research. Improvements of their proprietary Clinical Peptidomics technologies were presented at this year's...

Microarrays donated to Vanderbilt University.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Agilent Technologies, Inc., (A) and Vanderbilt University Medical Center (VUMC) announced that Agilent has donated cDNA microarray kits valued at $66,000 to the medical center. VUMC expects to use...

More than 1 million Bioanalyzer chips sold.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Agilent Technologies, Inc., (A) announced that it has sold more than one million LabChip chips - small, analytical devices used with the Agilent 2100 bioanalyzer to perform fast, automated analysis of...

District of Columbia EHMSA licenses VisualDx diagnostic software.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Logical Images, a developer of point-of-care medical-diagnostic software, announced that VisualDx will support clinicians at 10 District of Columbia hospital emergency departments and 20 District of...

Anticancer effects of DADS characterized.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- The anticancer effects of diallyl disulfide (DADS) have been further characterized. DADS, "one of the major components of garlic (Allium sativum), is well known to have chemopreventative activity...

Gen-Probe signs licensing agreements.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Gen-Probe (GPRO) has signed nonexclusive licensing agreements with bioMerieux and its affiliates that provide bioMerieux options to access Gen-Probe's ribosomal RNA technologies for certain uses, and...

Chiron announces blood-screening licensing agreement.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Chiron Corp. (CHIR) has granted a nonexclusive license to the blood transfusion centers of the German Red Cross (Blutspendediensten des Deutsche Rotes Kreuz, or DRK) for use of the company's HIV-1 and...

Clinical bovine mastitis diagnosed in a Prototheca zopfii outbreak.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Clinical bovine mastitis was diagnosed in a Prototheca zopfii outbreak. According to a study from Brazil, "Biopsy by fine needle aspiration together with microbiological examination and scanning...

Analysis: New York City women continue to receive fewer mammograms.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Women in New York City continue to receive mammograms at much lower levels than those outside the downstate region, while Kings County (Brooklyn) still has the lowest county-specific mammography rate,...

Breast density, second breast cancer in women with ductal carcinoma studied.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Having highly dense breasts may be associated with an increased risk of a second breast cancer among women who have had a ductal carcinoma in situ (DCIS), according to a study in the October 6 issue of...

China's FDA approves laser breast imaging device.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Imaging Diagnostic Systems, Inc., (IMDS) announced that its CT Laser Mammography system (CTLM) has received Chinese State Food and Drug Administration (SFDA) marketing approval. Following extensive...

Genetic tumor virulence markers identified in murine model.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Genetic markers of tumor virulence have been identified in a murine model of breast cancer. "FVB/N-Tg (MMTV-PyMT)[superscript]634Mul-transgenic mice develop multifocal mammary tumors with a high...

Georgia medical center displays largest pink ribbon for breast cancer awareness.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- The typical fall colors at Southern Regional Medical Center (SRMC) will be infused with a hue more commonly associated with spring: pink. A 30-foot-long, 5-foot-wide banner of pink ribbon hangs on...

LifeShirt System measures cardiopulmonary parameters in breast cancer study.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Researchers at the Tom Baker Cancer Center and University of Calgary are using the LifeShirt System from VivoMetrics in combination with the Mindfulness Based Stress Reduction program (MBSR) to help...

Medical technology company receives financing to introduce BreastScanIR.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Infrared Sciences Corporation (ISC) announced that it has completed a $1 million series A preferred stock financing, acquiring the capital necessary to introduce BreastScan IR to a broader market of...

Well-differentiated breast tumors have more 16q loss than poorly differentiated.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Well-differentiated breast tumors have more 16q loss than poorly differentiated tumors. According to a study from the Netherlands, "Loss of heterozygosity (LOH) at the long arm of chromosome 16 is a...

Healthcare company encouraged by NCI silicone gel-filled breast implants study.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- INAMED Corporation (IMDC) reported that they are encouraged by results published in the October 1, 2004, issue of the American Journal of Epidemiology in which researchers at the U.S. National Cancer...

Botox could play a key role in pain control during breast reconstruction.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Botox, a household name for wrinkle reduction, could be assuming a new role as a pain reliever. In a study presented October 10, 2004, at the American Society of Plastic Surgeons (ASPS) Plastic...

Plastic surgeons perform first entire face reconstruction.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Hundreds of thousands of people are burned in fires each year with many suffering from facial burns as a result. These burn victims not only have severe physical scars, but deep emotional scars, too....

Ernst & Young, LLP, resigns from audit of device company.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Vascular Solutions, Inc., (VASC) announced that Ernst & Young, LLP, has resigned as independent auditor of Vascular Solutions, Inc., due solely to Ernst & Young's stated lack of available personnel to...

GOLD'n GRO sales up 103% in first 9 months of 2004, third quarter sales up 194%.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Itronics Inc. (ITRO) reported that GOLD'n GRO sales by its subsidiary, Itronics Metallurgical, Inc., for the first 9 months of 2004 totaled approximately $858,000, a 103% increase over the prior year's...

Medical technology company announces results of shareholder audit.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- NanoSignal Corp. (Pink Sheets: NNOS) has determined, after an extensive review of a detailed shareholder audit, conclusive and stunning documented proof of the market making activity involving the...

Radiation therapy services management company added to Russell Indexes.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Radiation Therapy Services, Inc., (NASDAQ:RTSX) announced that it has been added to the Russell 3000 and Russell 2000 Indexes. Dr. Daniel Dosoretz, president and chief executive officer, stated,...

Agilent Technologies to partner in bioinformatics work on $11.7M ATP grant.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Icoria, Inc., (ICOR) announced that Agilent Technologies has been approved by the U.S. National Institute of Standards and Technology (NIST) Advanced Technology Program (ATP) to partner with Icoria in...

Agreement signed for distribution of bacterial detection system in Japan.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Pall Corporation (NYSE:PLL) announced that it has finalized an agreement for Kawasumi Laboratories, Inc., to become the exclusive provider of the Pall eBDS (enhanced Bacterial Detection System) in...

Ambulatory care company announces mergers, financials, name change at meeting.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- SurgiCare Inc. (SRG), a Houston, Texas-based ambulatory surgery company, held its special meeting in lieu of an annual meeting of stockholders at its corporate headquarters in Houston. At the...

Builders of largest insulin plant receive Award for Engineering Excellence.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- The life science engineering company NNE was awarded the Haden Freeman Award for Engineering Excellence on September 28, 2004 for the fast track construction of the world's largest insulin plant built...

Cancer research foundation announces new partnership.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- The Lance Armstrong Foundation (LAF) has announced a 5-year, $500,000 gift to the Nevada Cancer Institute (NVCI) to establish the Lance Armstrong Foundation Survivorship Center at the Institute. The new...

Cardiology instrument designer and manufacturer added to Russell Indices.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Stereotaxis, Inc. (STXS) announced that it has been added to the Russell 3000 and Russell 2000 Indices, as of October 1, 2004. "As a company that has recently completed an initial public offering,...

Chemistry-focused software developer expands facilities, names division heads.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Synthematix, Inc., a provider of chemistry reaction planning and knowledge management systems, has expanded its office space and added several employees in response to an expanding customer base and...

Drug-testing company expands operations with move to new facilities.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Cozart, plc, announced their move to new premises on the Milton Park estate in Abingdon, Oxford, U.K. Cozart is a medical-diagnostics company which provides immunodiagnostic tests, particularly...

Johnson & Johnson third-quarter profit rises 13%.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Healthcare giant Johnson & Johnson reported a 13% surge in profits October 12, 2004, and again raised its outlook for the full year, as a 10.5% increase in worldwide sales helped offset a mixed...

Medical monitoring service changes stock symbol.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Medeorex, Inc., (MRXI) announced that it has completed a change in its stock trading symbol on the NASD Over-The-Counter Bulletin Board to "MRXI" from "CXTX." The company previously changed its...

Online science supplier expanding operations.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Online science supplier LabX announced a staff increase and expanded operations that will accommodate the accelerated growth of their online equipment marketplace. The company said that it is added...

Orthopedic products company presented technology overview at conference.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- ReGen Biologics, Inc., (OTC:RGBI) announced that Gerald E. Bisbee, Jr., PhD, chairman and chief executive officer of ReGen Biologics, will presented an overview of the company's technology and business...

Pharmaceutical company announces plan to sell Clontech.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Becton, Dickinson and Company (BD, BDX) announced that its board of directors had approved a plan to sell the company's Clontech operation, a unit of BD Biosciences. "The plan to sell Clontech is a...

University study affirms efficacy of pheromone-based products, company says.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Human Pheromone Sciences, Inc. (EROX) confirmed that an independent study conducted by researchers at the University of California, Berkeley, and published in the journal, Psychoneuroendocrinology,...

Pharmacological unmasking microarray identifies tumor suppressor genes.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- A novel microarray analysis technique facilitates the identification of tumor suppressor genes. "Aberrant promoter hypermethylation of tumor suppressor genes is proposed to be a common feature of...

Changes made to computed radiography system.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- At the recent American Society for Therapeutic Radiology and Oncology meeting, Eastman Kodak Company announced changes to its computed radiography system, called KODAK 2000RT CR Plus. The company...

Biopharma company announces update on trial of compound for advanced cancers.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- NeoPharm (Nasdaq:NEOL) announced that results from a phase I clinical trial of the company's NeoLipid compound LE-SN38 in patients with advanced cancers were presented at the 16th Symposium on Molecular...

DOD awards sole-source contract for the ThinPrep Pap Test.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Cytyc Corp. (CYTC) announced that it has won a sole-source contract from the United States Department of Defense (DOD) to provide the ThinPrep Pap Test as the platform for cervical cancer screening at...

Anticancer activity of Scutellaria barbata characterized.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- The anticancer effects of Scutellaria barbata extract have been characterized. S. barbata, "a traditional Chinese herbal medicine native to southern China, is widely used as an anti-inflammatory and...

Biliary excretion of imatinib mesylate and metabolite characterized.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- The biliary excretion of imatinib mesylate and its metabolite has been characterized. "Imatinib mesylate, licensed to treat chronic myelogenous leukemia and gastrointestinal stromal tumors, is...

Compounds with MDR1-enhanced anticancer activity identified.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Several novel anticancer compounds have demonstrated heightened activity in the presence of the MDR1 multidrug transporter. "For analysis of multidrug resistance, a major barrier to effective...

Emory announces first clinical use of Trilogy system for cancer treatment.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Emory University School of Medicine's department of radiation oncology has become the first cancer treatment center in the world to use the new Trilogy system from Varian Medical Systems (VAR), for...

Flow cytometric assay provides measure of transient tumor hypoxia.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- A novel flow cytometric assay enables quantification of transient tumor hypoxia. "Transient hypoxia is a poorly understood and potentially important factor that may limit tumor response to various...